Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
about
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review StudyAzilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapyEffect of Azilsartan on Day-to-Day Variability in Home Blood Pressure: A Prospective Multicenter Clinical Trial.Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.Macro- and microvascular endothelial dysfunction in diabetes.Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic MouseAT1 Receptor Modulator Attenuates the Hypercholesterolemia-Induced Impairment of the Myocardial Ischemic Post-Conditioning BenefitsVascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure.Azilsartan as "Add-On" Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis.A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3.Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway
P2860
Q26740629-16E39815-775D-41B4-B8C3-A7EB89EE1CC5Q26751126-5625E5B7-3F2B-42DD-9170-8BE2FE5C130DQ33763329-8B22E311-C93B-4689-9ED5-8D8D1C2B8BFEQ35382532-71BE4016-DCE1-4602-ABC9-C3EC83CFD2F6Q39065434-D61D96EB-9C14-4CD1-A4D6-247EDF4C7CE1Q41579741-07F29D29-C330-4C65-9A71-375503BEA767Q42083035-FDA5C8F8-62D6-44F7-B56F-33C5171B43EDQ42837025-F6148DB1-CB5D-4667-AE8E-693F4F51AC2DQ55176650-750E4265-C779-49D4-B9BB-53E3928B3AD5Q55382850-8F3D3A6A-8AF8-49E2-B616-A5008C43AC3BQ58805576-47ED12EE-100C-49B3-AD28-0ADCEB96F058
P2860
Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Azilsartan, an angiotensin II ...... ide synthase in diabetic mice.
@en
type
label
Azilsartan, an angiotensin II ...... ide synthase in diabetic mice.
@en
prefLabel
Azilsartan, an angiotensin II ...... ide synthase in diabetic mice.
@en
P2093
P2860
P356
P1476
Azilsartan, an angiotensin II ...... ide synthase in diabetic mice.
@en
P2093
Daiju Fukuda
Hiroaki Masuzaki
Ken Yamakawa
Masataka Sata
Sachiko Matsumoto
Takeshi Soeki
P2860
P2888
P356
10.1186/1475-2840-13-30
P407
P577
2014-01-31T00:00:00Z
P5875
P6179
1002198400